Phase 1 maximal-use pharmacokinetics (PK) study completed in support of planned U.S. label expansionData to complement previously announced positive Phase 3 efficacy results on extremities, neck and ...
BENGALURU: A Vishnu Sai Theja, a student of Narayana CO School, Kaveri Bhavan, in Bengaluru, has emerged as the state topper in JEE Phase 1 exams with an overal ...
Innovent Biologics, Inc. (Innovent,HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, ...
ASCEND to evaluate CR-001, a PD-1 x VEGF bispecific antibody, in multiple solid tumor types, including NSCLC and gastrointestinal and gynecological cancers in first-line and previously treated patient ...
(Willmar MN-) The Willmar City Council will hold a bond hearing during tonight's meeting for Phase 1 of the Willmar Connect ...
Dr. Raza Bokhari, Exec Chairman & CEO, Interviewed by Bloomberg Open Interest Anchor Matt Miller PHILADELPHIA, PA / ACCESS Newswire / February 12, 2026 / Medicus Pharma Ltd. (NASDAQ:MDCX) (“Medicus” ...
Eli Lilly is paying $100 million upfront for the right to develop CSL’s phase 3-stage IL-6 antibody that had previously been ...
Del-desiran (also known as AOC1001) is an antibody-oligonucleotide conjugate comprised of a DMPK small interfering RNA (siRNA ...
Randomized, placebo-controlled Phase 2a study of SPL026 met its primary endpoint demonstrating a clinically significant reduction in depressive ...
GlobalData on MSN
CStone secures FDA clearance to begin CS2009 Phase II trial
Recruitment is ongoing in China and Australia, with IND clearance now obtained in the US.
BridgeBio is hoping infigratinib will get another shot at approval after the medicine hit the key goals of a phase 3 study in ...
VANCOUVER, BC , Feb. 18, 2026 /CNW/ - Luca Mining Corp. ("Luca" or the "Company") (TSX-V: LUCA) (OTCQX: LUCMF) (Frankfurt: Z68) is pleased to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results